Genflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalyst
3:39
Genflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalyst
1 week ago
YahooProactive
Mammoth Biosciences CEO on Business Outlook
7:28
Mammoth Biosciences CEO on Business Outlook
5 months ago
MSNBloomberg
Genflow Biosciences CEO: key catalysts for 2026
Genflow Biosciences CEO: key catalysts for 2026
3 months ago
proactiveinvestors.co.uk
Genflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalyst
Genflow Biosciences CEO on Acuitas collaboration: non-dilutive growth catalyst
1 week ago
proactiveinvestors.com
This CEO Is Creating A Vaccine To Cure Breast Cancer - Meet Dr. Amit Kumar, CEO of Anixa Biosciences | Anixa Biosciences, Inc.
This CEO Is Creating A Vaccine To Cure Breast Cancer - Meet Dr. Amit Kumar, CEO of Anixa Biosciences | Anixa Biosciences, Inc.
2.5K views4 weeks ago
linkedin.com
Negotiating from a position of strength: Genflow Biosciences CEO explains AGM RNS
Negotiating from a position of strength: Genflow Biosciences CEO explains AGM RNS
2 months ago
proactiveinvestors.co.uk
Genflow Biosciences: AGM and partnership strategy - ICYMI
Genflow Biosciences: AGM and partnership strategy - ICYMI
2 months ago
proactiveinvestors.co.uk
Genflow CEO on promising SLAB trial data - ICYMI
2 weeks ago
proactiveinvestors.com
Lexaria Bioscience CEO: Faster, Cost-efficient Drug Delivery Platform for COVID-19 and Beyond
Jun 28, 2021
investingnews.com
Genflow CEO on promising SLAB trial data and next steps in dog trial
3 weeks ago
proactiveinvestors.com
Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO
Jun 15, 2023
proactiveinvestors.co.uk
NeonMind Biosciences Inc. Announces CEO Changes
Dec 9, 2022
marketscreener.com
Willow Biosciences CEO confident in future after record revenue and new partnerships - ICYMI
Aug 16, 2024
proactiveinvestors.com
School of Biosciences
5 months ago
cardiff.ac.uk
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium
Apr 9, 2025
finanznachrichten.de
Castle Biosciences, Inc. | LinkedIn
Jan 15, 2021
linkedin.com
Jurassic World Rebirth's Science Could Revive One Extinct Animal In Just Three Years, Says Colossal Biosciences CEO
10 months ago
screenrant.com
Innovating Biologics To Make Healthcare More Accessible: Enzene Corporate Video
Nov 12, 2024
ambitionbox.com
Genflow Biosciences CEO on key first-half progress in longevity programs
Sep 30, 2024
proactiveinvestors.com
1:46
Prometheus Biosciences CEO on the company's ability to raise capital, get FDA approval
Dec 10, 2022
CNBC
Genflow Biosciences CEO discusses progress towards a European patent for SIRT6 variant
Feb 21, 2025
proactiveinvestors.com
Genflow Biosciences CEO Reveals the Secrets of Longevity: An Exclusive Interview with Dr Eric Leire
Sep 19, 2023
proactiveinvestors.com.au
Genflow Biosciences CEO discusses positive progress in lead longevity programmes
9 months ago
proactiveinvestors.co.uk
Genflow Biosciences CEO welcomes new investment; outlines dog longevity trial
Mar 26, 2025
proactiveinvestors.co.uk
Genflow Biosciences CEO on FY24 progress, dog study and other upcoming milestones
1 year ago
proactiveinvestors.co.uk
Anisa Kalinowski and Halo Biosciences: Revolutionizing the Treatment of Inflammation and Fibrosis
Jun 9, 2023
stanford.edu
Genflow Biosciences reaffirms commitment to new markets
May 12, 2023
proactiveinvestors.co.uk
Genflow Biosciences hits safety milestone in dog ageing trial
8 months ago
proactiveinvestors.co.uk
4:25
Novartis CEO: We're never done with M&A
6 months ago
MSNCNBC
4:43
Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct animals or saving endangered ones. Read more: http://on.forbes.com/6188LSG5q | Forbes
1.3K viewsMar 4, 2025
FacebookForbes
See more